Respectfully, some of the claims in this piece are not accurate, or seem to misunderstand how a business like Roivant actually works (or any publicly traded company, tbh).
Example:
"Despite never having created anything in his life other than a series of companies engaged in various blatant scams, Forbes recently estimated Ramaswamy's net …
Respectfully, some of the claims in this piece are not accurate, or seem to misunderstand how a business like Roivant actually works (or any publicly traded company, tbh).
Example:
"Despite never having created anything in his life other than a series of companies engaged in various blatant scams, Forbes recently estimated Ramaswamy's net worth to be more than $950 million."
Read the first half of that sentence back to yourself. In the same breath you are stating that he has created nothing of value... but also that he has founded a series of companies (one of which is now a multibillion dollar, publicly traded company, Roivant).
The idea for Roivant was genius. You may not *like* the idea, because it's biotech, but the idea itself was killer and that's why people invested. Their pipeline is strong, which is why the stock growth has been strong. The 2022 stock bump was when their promising monoclonal antibody entered PH2 of it's trials, and other pipeline drugs were looking good too. It's not a "scam" or a "ponzi scheme", it's a drug dev company that selects it's candidates from the cutting floor of much bigger firms, and retests them to find the gems.
Not all the drugs they buy the IP turn out to be winners. Some (most actually) fail. But they acquire the IP at very low cost, and with some of the testing already done. Very clever business model.
Respectfully, some of the claims in this piece are not accurate, or seem to misunderstand how a business like Roivant actually works (or any publicly traded company, tbh).
Example:
"Despite never having created anything in his life other than a series of companies engaged in various blatant scams, Forbes recently estimated Ramaswamy's net worth to be more than $950 million."
Read the first half of that sentence back to yourself. In the same breath you are stating that he has created nothing of value... but also that he has founded a series of companies (one of which is now a multibillion dollar, publicly traded company, Roivant).
The idea for Roivant was genius. You may not *like* the idea, because it's biotech, but the idea itself was killer and that's why people invested. Their pipeline is strong, which is why the stock growth has been strong. The 2022 stock bump was when their promising monoclonal antibody entered PH2 of it's trials, and other pipeline drugs were looking good too. It's not a "scam" or a "ponzi scheme", it's a drug dev company that selects it's candidates from the cutting floor of much bigger firms, and retests them to find the gems.
Not all the drugs they buy the IP turn out to be winners. Some (most actually) fail. But they acquire the IP at very low cost, and with some of the testing already done. Very clever business model.